A new study published in the journal of Neurology revealed that semaglutide may increase the risk of non-arteritic anterior ...
CDSCO asks SLAs to take strict action against violation of regulations on GLP-1 based weight loss drugs: Gireesh Babu, New Delhi Wednesday, May 20, 2026, 08:00 Hrs [IST] The Centr ...
New research presented at the European Congress on Obesity in Istanbul, Turkey (May 12–15) shows the use of the new GLP-1 ...
By combining novel measures of brain function with a brain-penetrant dual GLP-1/GIP agonist program, NeuraLight and Kariya Pharmaceuticals aim to tackle one of neurodegeneration's central challenges: ...
New research presented at this year’s European Congress on Obesity in Istanbul, Turkey (12-15 May) shows the use of the new ...
Adults with T1D who receive GLP-1-based therapy may have a lower risk for adverse cardiovascular outcomes and no significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results